Examiner: GEORGE, DENNIS CHERIAN

Tech Center 1600 • Art Units: 1644

This examiner grants 38% of resolved cases

Performance Statistics

38.5%

Allow Rate

-21.5% vs TC avg

Total Applications

+72.7%

Interview Lift

1308

Avg Prosecution Days

Based on 13 resolved cases, 2023–2026

4.3%

§101 Eligibility

12.9%

§102 Novelty

26.7%

§103 Obviousness

26.7%

§112 Clarity

App #	Title	Status	Assignee
17416859	T-CELL RECEPTOR MODIFIED OBJECT	Final Rejection	Takeda Pharmaceutical Company Limited
17442461	PROTEINACEOUS HETERODIMER AND USE THEREOF	Final Rejection	SHIHUIDA PHARMACEUTICAL GROUP (JILIN) CO., LTD.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.